Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeGet Started Book a Demo

Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Bio N Tech Appoints Guido Oelkars As Chief Executive Officer

PUBLIC · BNTXAug 03, 2026•6 days ago

Position

Chief Executive Officer

Company

BioNTech

Guido Oelkars

MainzBiotechnologyHealth CareTherapeuticsBiopharma

Description

BioNTech has appointed Guido Oelkars as its new Chief Executive Officer. He will officially start his role on February 1, 2027.

Company Information

Company

BioNTech

Location

Mainz, Rhineland Palatinate, Germany

About

BioNTech is a biopharmaceutical company dedicated to harnessing the power of the immune system to develop innovative cancer therapies and treatments for other serious diseases.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for BioNTech's next move

Learn about Strategic plan

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months